Brief: Akoya Biosciences Discloses Termination Fees for Deal With Quanterix
10/01/2025 14:05
Jan 10 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA BIOSCIENCES INC - QUANTERIX TO PAY $9 MILLION
TERMINATION
FEE IF MERGER TERMINATED-SEC FILING
* AKOYA BIOSCIENCES INC: AKOYA TO PAY QUANTERIX A
TERMINATION FEE
OF $7 MILLION IF THE MERGER AGREEMENT IS TERMINATED
Source text: https://shorturl.at/XwMgO
Further company coverage: AKYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview